Lixte Biotechnology Holdings, Inc. Warrants Share Price
LIXTWLixte Biotechnology Holdings, Inc. Warrants Stock Performance
Open $0.16 | Prev. Close $0.12 | Circuit Range N/A |
Day Range $0.16 - $0.16 | Year Range $0.02 - $0.38 | Volume 1,547 |
Average Traded $0.16 |
Lixte Biotechnology Holdings, Inc. Warrants Share Price Chart
About Lixte Biotechnology Holdings, Inc. Warrants
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Lixte Biotechnology Holdings, Inc. Warrants Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
28-Oct-25 | $0.16 | $0.16 | +32.50% |
09-Oct-25 | $0.12 | $0.12 | -50.00% |
03-Sep-25 | $0.24 | $0.24 | +20.60% |
28-Aug-25 | $0.23 | $0.20 | -0.50% |
05-Aug-25 | $0.20 | $0.20 | -13.04% |
04-Aug-25 | $0.23 | $0.23 | +43.75% |
15-Jul-25 | $0.16 | $0.16 | -51.52% |
FAQs on Lixte Biotechnology Holdings, Inc. Warrants Share Price
Can I buy Lixte Biotechnology Holdings, Inc. Warrants shares in India?
What is the share price of Lixte Biotechnology Holdings, Inc. Warrants?
What is the 5 year returns of Lixte Biotechnology Holdings, Inc. Warrants?
What are the high & low stock price of Lixte Biotechnology Holdings, Inc. Warrants today?
What is the 52-week high and low of Lixte Biotechnology Holdings, Inc. Warrants stock?